Received Nov 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 94CC4 | — |
Expired dose given; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 61-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 94CC4, expiry date 25-OCT-2025) for prophylaxis. On 04-NOV-2025, the patient received Arexvy. On 04-NOV-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 04-NOV-2025 The vaccine administration facility was the same as Primary Reporter A registered nurse called in to request data about the administration of an expired dose of Arexvy vaccine.